118 related articles for article (PubMed ID: 25637931)
21. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
Sodee DB; Sodee AE; Bakale G
Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
[TBL] [Abstract][Full Text] [Related]
22. First description of the role of ¹⁸F-FDG-PET/CT as compared to CT, MRI to suspect a case of thymoma in a pediatric patient.
Tsuchida T; Kinoshita S; Kawakita A; Yasutomi M; Tanizawa A; Kimura H
Hell J Nucl Med; 2012; 15(1):68-9. PubMed ID: 22413119
[No Abstract] [Full Text] [Related]
23. Brown adipose tissue in humans: detection and functional analysis using PET (positron emission tomography), MRI (magnetic resonance imaging), and DECT (dual energy computed tomography).
Borga M; Virtanen KA; Romu T; Leinhard OD; Persson A; Nuutila P; Enerbäck S
Methods Enzymol; 2014; 537():141-59. PubMed ID: 24480345
[TBL] [Abstract][Full Text] [Related]
24. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Watanabe H; Kanematsu M; Kondo H; Kako N; Yamamoto N; Yamada T; Goshima S; Hoshi H; Bae KT
J Magn Reson Imaging; 2010 May; 31(5):1151-6. PubMed ID: 20432351
[TBL] [Abstract][Full Text] [Related]
25. PET/CT and radiotherapy in prostate cancer.
De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021
[TBL] [Abstract][Full Text] [Related]
26. Hybrid imaging: which road to go?
Otte A
Hell J Nucl Med; 2007; 10(3):181. PubMed ID: 18271143
[No Abstract] [Full Text] [Related]
27. Functional response imaging following neoadjuvant therapy for rectal cancer.
Smeets P; Ceelen W
Surg Technol Int; 2009 Apr; 18():93-7. PubMed ID: 19579194
[TBL] [Abstract][Full Text] [Related]
28. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
Pace L; Salvatore M; Del Vecchio S
J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
[No Abstract] [Full Text] [Related]
29. Imaging prostate cancer.
Jung AJ; Westphalen AC
Radiol Clin North Am; 2012 Nov; 50(6):1043-59. PubMed ID: 23122037
[TBL] [Abstract][Full Text] [Related]
30. Developments of magnetic resonance imaging and spectroscopy in the field of molecular imaging.
Aime S; Bisi G
Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):563-4. PubMed ID: 20016449
[No Abstract] [Full Text] [Related]
31. Nanoparticles for molecular imaging--an overview.
Minchin RF; Martin DJ
Endocrinology; 2010 Feb; 151(2):474-81. PubMed ID: 20016027
[TBL] [Abstract][Full Text] [Related]
32. Incidental detection by [11C]choline PET/CT of meningiomas in prostate cancer patients.
Fallanca F; Giovacchini G; Picchio M; Bettinardi V; Messa C; Fazio F
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):417-21. PubMed ID: 19282812
[TBL] [Abstract][Full Text] [Related]
33. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
[No Abstract] [Full Text] [Related]
34. Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.
Monet A; Merino B; Lupo R
Clin Nucl Med; 2010 Jan; 35(1):34-5. PubMed ID: 20026972
[No Abstract] [Full Text] [Related]
35. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
36. Editorial Comment to Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging?
Wetter A
Int J Urol; 2014 Dec; 21(12):1288. PubMed ID: 25138830
[No Abstract] [Full Text] [Related]
37. Anatomic and Molecular Imaging in Prostate Cancer.
Miller ET; Salmasi A; Reiter RE
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28710256
[TBL] [Abstract][Full Text] [Related]
38. [Molecular imaging in cancer therapy].
Weber WA
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):810-7. PubMed ID: 20700780
[TBL] [Abstract][Full Text] [Related]
39. Giant Multilocular Cystadenoma of the Prostate.
Baad M; Ericson K; Yassan L; Oto A; Eggener S; Nottingham CU; Richards KA; Thomas S
Radiographics; 2015; 35(4):1051-5. PubMed ID: 26172350
[No Abstract] [Full Text] [Related]
40. Prostate cancer imaging.
Picchio M; Piert M
Eur J Nucl Med Mol Imaging; 2013 Jul; 40 Suppl 1():S1-4. PubMed ID: 23775347
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
